Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protalix BioTherapeutics

2.97
+0.12004.21%
Volume:396.22K
Turnover:1.13M
Market Cap:231.76M
PE:81.03
High:2.97
Open:2.86
Low:2.76
Close:2.85
Loading ...
May 14, 2021

Major Issues Report

8-K - Current report
Apr 30, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 28, 2021

Major Issues Report

8-K - Current report
Mar 30, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2021

Major Issues Report

8-K - Current report
Feb 23, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 30, 2020

Major Issues Report

8-K - Current report
Nov 24, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 29, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2020

Major Issues Report

8-K - Current report
Oct 23, 2020

Major Issues Report

8-K/A [Amend] - Current report
Oct 01, 2020

Major Issues Report

8-K - Current report
Sep 08, 2020

Major Issues Report

8-K - Current report